Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
75 participants
INTERVENTIONAL
2013-05-31
2013-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
A Clinical Evaluation Pilot Study of the Efficacy of Blink® Tears Lubricant Eye Drops for the Relief of Dry Eye Symptoms Following Implantation of Tecnis® Multifocal Introcular Lens
NCT01061268
Study of Safety and Performance of a Novel Ocular Lubricant in Subjects With Dry Eye Disease
NCT06444516
Tear Film Break-Up Time Evaluation of FID 114657
NCT01023464
An Evaluation of the Nighttime Retention of Effect of an Investigational Lubricant Eye Drop (FID 115958D)
NCT01165164
Study of Efficacy and Tolerability of SYSTANE Complete in Patients With Dry Eye Disease
NCT03492541
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
FID 119515A
FID 119515A, 1 drop instilled in the study eye, single dose
FID 119515A
topical ocular drops
Blink
Blink® Tears, 1 drop instilled in the study eye, single dose
Blink® Tears
topical ocular drops
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
FID 119515A
topical ocular drops
Blink® Tears
topical ocular drops
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Best corrected visual acuity (BCVA) of 55 or greater in each eye as measured by an ETDRS chart (letters read method).
* At least a 3 month documented history of dry eye in both eyes.
* TBUT and Ocular Surface Disease Index (OSDI) Questionnaire score as specified in protocol.
Exclusion Criteria
* Any evidence of ocular infection or inflammation within 30 days prior to Screening.
* Any ocular surgery.
* Ocular trauma requiring medical or pharmacological treatment within 1 year of Screening.
* Current presence of punctal plugs (permanent or temporary) or previous permanent punctal closure by cautery/diathermy.
* Use of topical ocular prescription or non-prescription medications within 30 days of Screening.
* Participation in any other clinical trial within 30 days prior to Screening.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Alcon Research
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Lisa Lindsey, PhD
Role: STUDY_DIRECTOR
Alcon Research
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
C-12-021
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.